Cyient Limited reported its Q4 FY26 results, highlighting a $163.5 million revenue for its DET business. The company announced a strategic INR720 crore share buyback at INR1,125 per share, reflecting strong confidence in its long-term value. While core DET performance saw short-term volatility, the group is aggressively scaling its semiconductor segment, aiming for mid to high single-digit organic growth in FY27 and focusing on long-term capital discipline and AI-led operational efficiency.
Quarterly Financial Performance
For the fourth quarter ended March 31, 2026, Cyient Limited’s Design, Engineering, and Technology (DET) segment reported revenue of $163.5 million. Despite a sequential decline, the business achieved a 12.4% normalized EBIT margin. Gross margins for the quarter improved by 114 basis points sequentially, driven by operational efficiencies and structural cost interventions.
Strategic Capital Allocation
The Board of Directors has approved a major buyback program, intending to repurchase up to 6.4 million equity shares. The offer is set at INR1,125 per share, with a total outlay not exceeding INR720 crores. Promoters and key management personnel have explicitly opted out of the buyback, signaling their conviction in the company’s underlying fundamentals and long-term intrinsic value.
Semiconductor Business Growth
Cyient continues to establish itself as a dominant player in the custom chip market. The semiconductor business delivered $7.2 million in Q4 revenue, marking its fourth consecutive quarter of growth. The company successfully closed a 74% majority stake in Kinetic Technologies and secured the MeitY-backed Semiconductor Complex of India Limited fab modernization program. Plans are underway to raise equity for this standalone subsidiary to support further scaling and reach breakeven.
Strategic Outlook and AI Transformation
The company remains committed to its 40% to 50% payout policy. While a transaction identified as Project Astro has been paused due to evolving AI impacts and geopolitical uncertainties, the company is actively leveraging AI to drive productivity improvements of 20% to 30%. Leadership remains optimistic about FY27, targeting mid to high single-digit organic growth, supported by a healthy pipeline and new large-deal wins in connectivity and health care sectors.
Source: BSE
